• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Epidemiological Alert: Chikungunya increase in the Region of the Americas - PAHO/WHO

Mary Wilson

Well-known member
13 February 2023

In 2022, the number of cases and deaths due to chikungunya in the Region of the Americas were above the numbers reported in previous years. The first weeks of 2023 have seen this trend continuing with the increase in cases and deaths becoming more evident. Due to this increasing trend, the Pan American Health Organization / World Health Organization (PAHO/WHO) recommends Member States intensify actions to prepare health care services, including the diagnosis and proper management of cases, to face possible outbreaks of chikungunya and other arboviral diseases, to minimize deaths and complications from these diseases.

Situation summary

Between epidemiological week (EW) 1 and EW 52 of 2022, a total of 271,176 cases of chikungunya1, including 95 deaths2,3, were reported in 13 of the countries and territories of the Region of the Americas. This figure is higher than that observed in the same period of 2021 (137,025 cases, including 12 deaths). During the first four epidemiological weeks of 2023, 30,707 cases and 14 deaths3 due to chikungunya were reported (Figure 1 and 2).

The increase in cases and deaths from chikungunya compared to the numbers reported in recent years are in addition to the simultaneous circulation of other arboviral diseases, such as dengue and Zika, both transmitted by the same vectors, Aedes aegypti (most prevalent) and Aedes albopictus, which are present in almost all countries and territories of the Region of the Americas. ...

Download and Preview:
https://www.paho.org/en/documents/epidemiological-alert-chikungunya-increase-region-americas
 
Source: file:///Users/lcr/Downloads/2023march08pheepialertchikven.pdf

Pan American Health Organization / World Health Organization. Epidemiological Alert:
Increase in cases and deaths from chikungunya in the Region of the Americas. 8 March 2023, Washington,
D.C: PAHO/WHO; 2023.
Pan American Health Organization • www.paho.org • © PAHO/WHO, 2023
Epidemiological Alert Increase in cases and deaths
from chikungunya in the Region of the Americas
8 March 2023

Situation summary1
Between epidemiological week (EW) 1 and EW 52 of 2022, a total of 273,685 cases of chikungunya, including 87 deaths, were reported in 14 of the countries and territories of the Region of the Americas. This figure is higher than that observed in the same period of 2021
(137,025 cases, including 12 deaths). During the first eight epidemiological weeks of 2023, 115,539 cases and 33 deaths due to chikungunya were reported (Figure 1 and 2), with the highest incidence rates observed in Paraguay (1,128 cases per 100,000 population) and Brazil (14.2 cases per 100,000 population).
The increase in cases and deaths from chikungunya compared to the numbers reported in recent years are in addition to the simultaneous circulation of other arboviral diseases, such as dengue and Zika, impacting on the overload of care services. These three diseases are
transmitted by the same vectors, Aedes aegypti (most prevalent) and Aedes albopictus, which are present in almost all countries and territories of the Region of the Americas.
 
Back
Top